An abstract to be presented by the American Academy of Neurology (CA, USA) reports patients suffering from hand tremors may find relief with a novel, non-invasive nerve stimulation treatment.
Browsing: Movement Disorders
Age/disease duration influence on activities of daily living and quality of life after levodopa-carbidopa intestinal gel in Parkinson’s disease
This research article from Neurodegenerative Disease Management investigates how age and disease duration affects Parkinson’s treatment outcome with levodopa-carbidopa intestinal gel.
NCTalks on neuromodulation in children: an interview with Jean-Pierre Lin, President of the British Paediatric Neurology Association
Dr Lin tells Lauren Pulling (Editor, NC) about his work as a pediatric neurologist, and recent advances in deep brain stimulation for infants.
#NCintroduces… Going through the motions: how modern techniques have changed the face of Parkinson’s research
Tom Naughton introduces the circuitry underlying Parkinson’s disease, and how our understanding and new techniques have advanced hand-in-hand to bring us to where we are now.
Dr Vitek discusses the Neuromodulation Research Center, progression in the field, and the biggest challenges associated with developing new neuromodulation therapies for conditions such as Parkinson’s disease.
Angelman syndrome and Dup15q syndrome: two rare diseases working together to solve each other’s puzzles – a conversation with Jill Silverman and Nathalie Buscher
In this interview, Drs Silverman and Buscher discuss their work, and how these two rare diseases are shedding light not only on each other, but also a wealth of other neurological disorders.
Is bone marrow transplantation a viable treatment option for relapsing–remitting MS? Jeffrey Cohen discusses pros and cons of the technique.
In this review, the authors highlight the recent progress in TD genetic research with a particular focus since 2011. They review genes involved in antipsychotic drug metabolism (pharmacokinetics) and those involved in drug targeting (pharmacodynamics), and provide a number of recommendations to move this area of research forward.
Scientists have developed a method of detecting a molecule linked to Parkinson’s disease in samples of spinal fluid taken from patients, a step that could one day help to improve early diagnosis of the disease.
A new model is proposed that the Basal Ganglia implement the level of transition control in an extended control hierarchy, helping to explain major neurological symptoms.